{
    "code": "02022859",
    "許可證字號": "衛署藥輸字第022859號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/04\/25",
    "發證日期": "89\/04\/25",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202285902",
    "中文品名": "憶思能膠囊6毫克",
    "英文品名": "EXELON CAPSULES 6MG",
    "適應症": "輕度至中度阿滋海默氏病之癡呆（失智）症。與帕金森氏症相關的輕度至中度癡呆（失智）症。",
    "劑型": "130膠囊劑",
    "包裝": "玻璃容器裝 鋁箔盒裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "主成分略述": "RIVASTIGMINE HYDROGEN TARTRATE",
    "限制項目": [
        "02輸入",
        "53依本署七七公告事項八得免除國內進行臨床試驗之特殊醫療需要之新藥"
    ],
    "申請商名稱": "1422701100  臺灣諾華股份有限公司",
    "申請商地址": "台北市中正區仁愛路二段99號11、12、13樓",
    "主製造廠": {
        "製造廠名稱": "F410106000  NOVARTIS FARMACEUTICA S.A.",
        "製造廠廠址": "RONDA SANTA MARIA,158,08210 BARBERA DEL VALLES BARCELONA,SPAIN",
        "製造廠公司地址": "",
        "製造廠國別": "SPAIN",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1204001410",
            "成分名稱": "RIVASTIGMINE HYDROGEN TARTRATE",
            "含量描述": "9.6",
            "含量": "9.6000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "濁紅橙\/鮮黃橙",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "長圓柱形",
        "標記一": "EXELON,6mg",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "圖片",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02022859&Seq=435&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 憶思能膠囊-TWI-090712-回二校 f___20121225.pdf 020228590033.jpg 020228590032.jpg 020228590031.jpg 020228590030.jpg 020228590029.jpg 020228590028.jpg 020228590027.jpg 020228590026.jpg 020228590025.jpg 020228590024.jpg 020228590023.jpg 020228590022.jpg 020228590021.jpg 020228590020.jpg 020228590019.jpg 020228590018.jpg 020228590017.jpg 020228590016.jpg 020228590015.jpg 020228590014.jpg 020228590013.jpg 020228590012.jpg 020228590011.jpg 020228590010.jpg 020228590009.jpg 020228590008.jpg 020228590007___20110705.jpg 020228590007.jpg 020228590006___20111025.jpg 020228590006___20110712.jpg 020228590006___20110705.jpg 020228590006.jpg 020228590005___20111025.jpg 020228590005___20110712.jpg 020228590005___20110705.jpg 020228590005.jpg 020228590004___20111025.jpg 020228590004___20110712.jpg 020228590004___20110705.jpg 020228590004.jpg 020228590003___20111025.jpg 020228590003___20110712.jpg 020228590003___20110705.jpg 020228590003.jpg 020228590002___20111025.jpg 020228590002___20110712.jpg 020228590002___20110705.jpg 020228590002.jpg 020228590001___20111025.jpg 020228590001___20110712.jpg 020228590001___20110705.jpg 020228590001.jpg 020228590001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02022859&Seq=054&Type=9"
        }
    ]
}